Redefining Prognosis of Transthyretin Cardiomyopathy in the Tafamidis Era. Zaghlol R, Rater M, Schiffer W, Mitchell JD, et al. J Card Fail 2022;28:1519-1521.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zaghlol R, Rater M, Schiffer W, Mitchell JD, et al. Redefining Prognosis of Transthyretin Cardiomyopathy in the Tafamidis Era. J Card Fail 2022;28:1519-1521.
PMID: 35988721